Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

OneMedNet (ONMDW) Shares Outstanding (Diluted Average) (2022 - 2025)

Historic Shares Outstanding (Diluted Average) for OneMedNet (ONMDW) over the last 4 years, with Q3 2025 value amounting to $52.6 million.

  • OneMedNet's Shares Outstanding (Diluted Average) rose 7979.84% to $52.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.6 million, marking a year-over-year increase of 7979.84%. This contributed to the annual value of $28.1 million for FY2024, which is 28614.3% up from last year.
  • OneMedNet's Shares Outstanding (Diluted Average) amounted to $52.6 million in Q3 2025, which was up 7979.84% from $38.4 million recorded in Q2 2025.
  • In the past 5 years, OneMedNet's Shares Outstanding (Diluted Average) ranged from a high of $52.6 million in Q3 2025 and a low of $4.0 million during Q4 2022
  • Over the past 4 years, OneMedNet's median Shares Outstanding (Diluted Average) value was $11.5 million (recorded in 2022), while the average stood at $19.4 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first crashed by 6492.9% in 2023, then soared by 58363.81% in 2024.
  • Quarter analysis of 4 years shows OneMedNet's Shares Outstanding (Diluted Average) stood at $4.0 million in 2022, then skyrocketed by 82.97% to $7.3 million in 2023, then skyrocketed by 286.14% to $28.1 million in 2024, then surged by 87.41% to $52.6 million in 2025.
  • Its last three reported values are $52.6 million in Q3 2025, $38.4 million for Q2 2025, and $34.1 million during Q1 2025.